DEVELOPMENT OF A WEST NILE VIRUS VACCINE
$440,933N01FY2016AINIH
Molecular Express, Inc., Rancho Dominguez CA
Investigators
Abstract
To demonstrate the utility of the VesiVax adjuvant platform in the development of an immunogenic West Nile Virus vaccine.
View original record on NIH RePORTER →